Nanjing Vazyme Biotech (688105.SS) Earnings Analysis
Nanjing Vazyme Biotech (688105.SS) next reports earnings on 2026-08-29. Trailing P/E -516.46.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688105.SS next report earnings?
| Next earnings date | 2026-08-29 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
688105.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | 0.01 CNY | n/a | n/a | n/a |
| 2026-02-26 | -0.0556 CNY | n/a | n/a | n/a |
| 2025-10-30 | 0.0095 CNY | n/a | n/a | n/a |
| 2025-08-29 | 0.0033 CNY | n/a | n/a | n/a |
| 2025-04-28 | 0.005 CNY | n/a | n/a | n/a |
| 2025-02-28 | -0.1 CNY | n/a | n/a | n/a |
| 2024-10-31 | 0.0071 CNY | n/a | n/a | n/a |
| 2024-08-28 | 0.0382 CNY | n/a | n/a | n/a |
688105.SS valuation and analyst view
| Trailing P/E | -516.46 |
|---|---|
| Trailing EPS | -0.03515 CNY |
| Price / book | 1.86 |
| Dividend yield | 2.95% |
| Market cap | 8.73B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Nanjing Vazyme Biotech (688105.SS)'s next earnings date?
Nanjing Vazyme Biotech is next scheduled to report on 2026-08-29.
Did 688105.SS beat earnings last quarter?
Consensus estimate data was not available for 688105.SS's 2026-04-22 report.
What is 688105.SS's current P/E ratio and EPS?
688105.SS trades at a trailing P/E of -516.46 on trailing EPS of -0.03514980629187873 CNY.
What do analysts rate 688105.SS?
688105.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.